
Glenmark, AbbVie ink $700 million drug licensing deal
Ichnos Glenmark Innovation (IGI), an alliance between New York-based scientific research group Ichnos Sciences and Mumbai-based Glenmark Pharmaceuticals, has signed an exclusive global licensing pact with US-based AbbVie to develop and commercialise IGI’s …